Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Andrew Fitton"'
Autor:
Andrew Fitton, Lynda R. Wiseman
Publikováno v:
CNS Drugs. 12:485-497
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8aaf1faf771f8f5a84e6d70c51e891a
https://doi.org/10.2165/00023210-199912060-00006
https://doi.org/10.2165/00023210-199912060-00006
Autor:
Andrew Fitton, Christopher J. Dunn
Publikováno v:
CNS Drugs. 5:224-230
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2b573e8348640b92514f1c18cf51507
https://doi.org/10.2165/00023210-199605030-00007
https://doi.org/10.2165/00023210-199605030-00007
Autor:
Lee B. Barradell, Andrew Fitton
Publikováno v:
CNS Drugs. 5:147-153
▴ Tandospirone is a new addition to the azapirone class of anxiolytics, which may be useful for the long term treatment of anxiety and depressive neuroses.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::538f8bfe70c85276efd3dd9a107ce656
https://doi.org/10.2165/00023210-199605020-00006
https://doi.org/10.2165/00023210-199605020-00006
Autor:
Lee B. Barradell, Andrew Fitton
Publikováno v:
Drugs. 50:714-741
Artesunate is an antimalarial agent, available in oral, rectal and parenteral formulations, that provides a rapid clinical effect in patients with Plasmodium falciparum malaria. The rapidity of effect, availability of an intravenous and intramuscular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3788c293a4cc18fdaf4292f51a77b17d
https://doi.org/10.2165/00003495-199550040-00009
https://doi.org/10.2165/00003495-199550040-00009
Autor:
David H. Peters, Andrew Fitton
Publikováno v:
Clinical Immunotherapeutics. 3:395-408
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d54f0e1d5d207df4960f9f2444b59319
https://doi.org/10.1007/bf03259504
https://doi.org/10.1007/bf03259504
Publikováno v:
Drugs & Aging. 6:243-262
Oxybutynin possesses anticholinergic and spasmolytic properties, which together form the basis for its use as a therapeutic option in patients with overactive detrusor function--either idiopathic detrusor instability (DI) or detrusor hyperreflexia. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60addee781458482fa07bb428d9fc804
https://doi.org/10.2165/00002512-199506030-00007
https://doi.org/10.2165/00002512-199506030-00007
Publikováno v:
Drugs & Aging. 5:446-474
Etidronic acid is an orally and intravenously active bisphosphonate, which is believed to inhibit resorption of bone via a number of cellular mechanisms, including alteration of osteoclastic activity. In studies of patients with symptomatic Paget's d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41dc6f2ed9955c8e4625214fc7eb400e
https://doi.org/10.2165/00002512-199405060-00006
https://doi.org/10.2165/00002512-199405060-00006
Publikováno v:
Drugs. 48:617-637
Loratadine is a long-acting antihistamine agent, exhibiting partial selectivity for peripheral histamine H1-receptors. To date, loratadine has been evaluated in allergic rhinitis, urticaria and, to a limited extent, in asthma. In several large contro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6c7274f73972b72ac3e9ef83a7bf0c
https://doi.org/10.2165/00003495-199448040-00009
https://doi.org/10.2165/00003495-199448040-00009
Autor:
Diana Faulds, Andrew Fitton
Publikováno v:
Clinical Immunotherapeutics. 2:307-323
Imciromab (monoclonal antimyosin antibody Fab) pentetate is a murine monoclonal antibody Fab (fragment antigen binding) derivative. It is specific for the human cardiac myosin heavy chain and localises to areas of cardiac myocyte necrosis. Indium In-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10323017fb34d885c60bcd8c51794711
https://doi.org/10.1007/bf03258530
https://doi.org/10.1007/bf03258530
Autor:
Andrew Fitton, Susan M. Grant
Publikováno v:
Drugs. 48:253-273
Risperidone, a benzisoxazol derivative, is a novel antipsychotic agent which combines potent serotonin (5-hydroxytryptamine) 5-HT2 and dopamine D2 receptor antagonism. Development of the drug was stimulated by reports that the selective serotonin 5-H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6300f923d1d0f3914f399190e8fdc909
https://doi.org/10.2165/00003495-199448020-00009
https://doi.org/10.2165/00003495-199448020-00009